Global Medical Isotope Systems
(GMIS) provides patent-pending systems for the production of medical isotopes for the nuclear medicine imaging industry. By introducing our safe, decentralized, on-demand production system we answer the critical supply needs of the industry while complying with nonproliferation objectives of the United States. The system technology is also scalable, allowing for custom deployments and ability to respond to unplanned needs. We intend to both operate facilities which supply nuclear pharmacies and to license the technology to other operators on a regional basis. By moving from the huge infrastructure required for reactor-based production to our system we are providing patients and doctors a much needed, secure, reliable source of isotopes.